State Requirement Info
Searching all 22 courses
1
/respiratory-therapy/ceus/course/rethinking-asthma-endotypes-and-phenotypes-1553
Rethinking Asthma – Endotypes and Phenotypes
We recognize the familiar phenotypes of asthma – exercise-induced bronchoconstriction(EIB), allergic, occupational, non-allergic, etc. However, understanding why patients with EIB, for example, may respond differently to the same treatment remains unclear. Identifying the mechanism behind the condition should, ideally, allow for precise - targeted treatment of these patients.
auditory, textual, visual
Rethinking Asthma – Endotypes and Phenotypes
Presented by Heather Murgatroyd, BA, RRT
Course: #1553Level: Advanced1 Hour
AARC - CRCE/1.0; CE Broker/1.0 Direct Delivery Of Respiratory Care Services, CE Broker #20-921423; IACET/0.1
We recognize the familiar phenotypes of asthma – exercise-induced bronchoconstriction(EIB), allergic, occupational, non-allergic, etc. However, understanding why patients with EIB, for example, may respond differently to the same treatment remains unclear. Identifying the mechanism behind the condition should, ideally, allow for precise - targeted treatment of these patients.
2
/respiratory-therapy/ceus/course/idiopathic-pulmonary-fibrosis-deadly-progressive-1484
Idiopathic Pulmonary Fibrosis: A Deadly Progressive Fibrotic Lung Disease
Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease affecting individuals worldwide. This advanced course provides familiarity with current literature findings in epidemiology, pathology, and diagnosis of IPF. In addition, this course reviews future therapeutic directions and clinical applications for best practice and management.
auditory, textual, visual
Idiopathic Pulmonary Fibrosis: A Deadly Progressive Fibrotic Lung Disease
Presented by Anoop Nambiar, MD, MS
Course: #1484Level: Advanced1 Hour
AARC - CRCE/1.0; CE Broker/1.0 Direct Delivery Of Respiratory Care Services, CE Broker #20-909669; IACET/0.1
Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease affecting individuals worldwide. This advanced course provides familiarity with current literature findings in epidemiology, pathology, and diagnosis of IPF. In addition, this course reviews future therapeutic directions and clinical applications for best practice and management.
3
/respiratory-therapy/ceus/course/autogenic-drainage-technique-for-airway-1560
Autogenic Drainage: Technique for Airway Clearance
An introductory course on autogenic drainage introduces the practitioner to this airway clearance technique focusing on the indications, procedure, and monitoring of patient outcomes.
auditory, textual, visual
Autogenic Drainage: Technique for Airway Clearance
Presented by Duane Reed, EdD, RRT, RCP
Course: #1560Level: Introductory1 Hour
AARC - CRCE/1.0; CE Broker/1.0 Direct Delivery Of Respiratory Care Services, CE Broker #20-921543; IACET/0.1
An introductory course on autogenic drainage introduces the practitioner to this airway clearance technique focusing on the indications, procedure, and monitoring of patient outcomes.
4
/respiratory-therapy/ceus/course/assessing-chronic-obstructive-pulmonary-disease-1447
Assessing the Chronic Obstructive Pulmonary Disease (COPD) Patient: More Than Spirometry
This intermediate course focuses on increasing the understanding and application of the assessment of the patient with chronic obstructive pulmonary disease. The course reviews the objective tests of function and patient-reported outcomes (PROs), which can provide valuable information on patient status and progress within disease management programs.
auditory, textual, visual
Assessing the Chronic Obstructive Pulmonary Disease (COPD) Patient: More Than Spirometry
Presented by Claire Aloan, MS, RRT-NPS, FAARC
Course: #1447Level: Intermediate1 Hour
AARC - CRCE/1.0; CE Broker/1.0 Direct Delivery Of Respiratory Care Services, CE Broker #20-911759; IACET/0.1
This intermediate course focuses on increasing the understanding and application of the assessment of the patient with chronic obstructive pulmonary disease. The course reviews the objective tests of function and patient-reported outcomes (PROs), which can provide valuable information on patient status and progress within disease management programs.
5
/respiratory-therapy/ceus/course/cardiovascular-disease-in-respiratory-care-1402
Cardiovascular Disease in Respiratory Care: Rethinking the Clinical Implications
This intermediate course provides a physiologic overview and evidence-based considerations of cardiovascular disease management in respiratory care. The course is designed to provide the listener with additional perspective and understanding in the critical care of patients with cardiovascular comorbidity.
auditory, textual, visual
Cardiovascular Disease in Respiratory Care: Rethinking the Clinical Implications
Presented by Tim Gilmore, PhD, RRT, RRT-ACCS, RRT-NPS, CPFT, AE-C
Course: #1402Level: Intermediate1 Hour
AARC - CRCE/1.0; CE Broker/1.0 Educational Techniques, CE Broker #20-871707; IACET/0.1
This intermediate course provides a physiologic overview and evidence-based considerations of cardiovascular disease management in respiratory care. The course is designed to provide the listener with additional perspective and understanding in the critical care of patients with cardiovascular comorbidity.
6
/respiratory-therapy/ceus/course/what-we-ve-learned-so-1407
What We’ve Learned So Far: Identification, Management and Impact of COVID-19 in Chronic Lung Disease
This course provides the steps in the identification of COVID-19 infection vs. chronic lung disease exacerbations, including the evolvement of management strategies for improving oxygenation and ventilator support for COVID-19 patients. The Biopsychosocial impact of this virus on the elderly and those with chronic lung disease is discussed.
auditory, textual, visual
What We’ve Learned So Far: Identification, Management and Impact of COVID-19 in Chronic Lung Disease
Presented by Nancy Nathenson, RRT
Course: #1407Level: Intermediate1 Hour
AARC - CRCE/1.0; CE Broker/1.0 Direct Delivery Of Respiratory Care Services, CE Broker #20-871677; IACET/0.1
This course provides the steps in the identification of COVID-19 infection vs. chronic lung disease exacerbations, including the evolvement of management strategies for improving oxygenation and ventilator support for COVID-19 patients. The Biopsychosocial impact of this virus on the elderly and those with chronic lung disease is discussed.
7
/respiratory-therapy/ceus/course/asthma-education-role-respiratory-therapist-1437
Asthma Education: The Role of the Respiratory Therapist
This advanced course is designed to guide respiratory therapists in the key components of asthma education when teaching patients and their families. The information presented in the webinar consists of relevant research, evidenced-based national asthma guidelines for clinical application, as well as the experience and training of the presenter.
auditory, textual, visual
Asthma Education: The Role of the Respiratory Therapist
Presented by Kevin Collins, PhD, RRT, RPFT, AE-C
Course: #1437Level: Advanced1.5 Hour
AARC - CRCE/1.5; CE Broker/1.5 Direct Delivery Of Respiratory Care Services, CE Broker #20-902017; IACET/0.2
This advanced course is designed to guide respiratory therapists in the key components of asthma education when teaching patients and their families. The information presented in the webinar consists of relevant research, evidenced-based national asthma guidelines for clinical application, as well as the experience and training of the presenter.
8
/respiratory-therapy/ceus/course/global-initiative-for-chronic-obstructive-1431
Global Initiative for Chronic Obstructive Lung Disease (Gold): COPD 2022 Updates
This intermediate course covers the current, evidence-based guidelines for the diagnosis, treatment, and rehabilitation of stable COPD and exacerbations of COPD. Course materials are provided by the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
auditory, textual, visual
Global Initiative for Chronic Obstructive Lung Disease (Gold): COPD 2022 Updates
Presented by Randy De Kler, MS, RRT
Course: #1431Level: Intermediate1 Hour
AARC - CRCE/1.0; CE Broker/1.0 Direct Delivery Of Respiratory Care Services, CE Broker #20-895773; IACET/0.1
This intermediate course covers the current, evidence-based guidelines for the diagnosis, treatment, and rehabilitation of stable COPD and exacerbations of COPD. Course materials are provided by the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
9
/respiratory-therapy/ceus/course/post-covid-19-pulmonary-sequelae-1393
Post-COVID-19Pulmonary Sequelae:Multiple Tsunamis of Patients with Long-term Respiratory Dysfunction
This advanced course focuses on the progression of "long COVID of the lungs," identifying current post-acute sequelae of the SARS-CoV-2 infection (PASC) involving the lungs with special focus on pulmonary fibrosis. The course reviews evidence-based literature on diagnosis and treatment intervention and post-COVID-19 initiatives for best practice management of pulmonary PASC.
auditory, textual, visual
Post-COVID-19Pulmonary Sequelae:Multiple Tsunamis of Patients with Long-term Respiratory Dysfunction
Presented by Anoop Nambiar, MD, MS
Course: #1393Level: Advanced1 Hour
AARC - CRCE/1.0; CE Broker/1.0 Direct Delivery Of Respiratory Care Services, CE Broker #20-872349; IACET/0.1
This advanced course focuses on the progression of "long COVID of the lungs," identifying current post-acute sequelae of the SARS-CoV-2 infection (PASC) involving the lungs with special focus on pulmonary fibrosis. The course reviews evidence-based literature on diagnosis and treatment intervention and post-COVID-19 initiatives for best practice management of pulmonary PASC.
10
/respiratory-therapy/ceus/course/bronchoscopic-tools-for-copd-valves-1377
Bronchoscopic Tools for COPD: Valves, Lung Denervation, and Liquid Nitrogen
New treatments for COPD have emerged for patients with emphysema and chronic bronchitis. This course provides an overview of these new therapies and where they may be applied now and in the future.
auditory, textual, visual
Bronchoscopic Tools for COPD: Valves, Lung Denervation, and Liquid Nitrogen
Presented by Charlie Strange, MD
Course: #1377Level: Advanced1 Hour
AARC - CRCE/1.0; CE Broker/1.0 Direct Delivery Of Respiratory Care Services, CE Broker #20-872333; IACET/0.1
New treatments for COPD have emerged for patients with emphysema and chronic bronchitis. This course provides an overview of these new therapies and where they may be applied now and in the future.